文献速递淋巴瘤

钙-RasGRP2-Rap1信号通路介导CD38诱导的慢性淋巴细胞白血病细胞迁移

Calcium-RasGRP2-Rap1 signaling mediates CD38-induced migration of chronic lymphocytic leukemia cells.
PubMed 文献 · Blood Adv · 2018-01-01

该研究探讨CD38高表达促慢性淋巴细胞白血病(CLL)细胞迁移的分子机制。CD38通过增加细胞内钙离子水平激活钙敏感性Rap1鸟嘌呤核苷酸交换因子RasGRP2,进而增强Ras家族GTP酶Rap1活性;Rap1与RasGRP2均为CLL细胞迁移所必需,且高CD38原代CLL细胞中RasGRP2呈极化分布。

要点

  • CD38表达升高增加CLL细胞基础细胞内钙离子水平并促进迁移。
  • CD38经钙离子激活RasGRP2,进而增强Rap1活性。
  • Rap1与RasGRP2均为CLL细胞迁移所必需。

核心结论

  • CD38通过增加细胞内钙离子水平,促进RasGRP2/Rap1介导的CLL细胞黏附与迁移。

研究设计与样本

  • 原文摘要未报告研究设计与样本量。

主要发现

  • CD38表达增加CLL细胞基础细胞内钙离子水平,并在有或无趋化因子刺激时均促进CLL细胞迁移。
  • CD38通过细胞内钙离子增加Ras家族GTP酶Rap1活性,Rap1受钙敏感性Rap1鸟嘌呤核苷酸交换因子RasGRP2调控。
  • Rap1和RasGRP2均为CLL细胞迁移所必需,高CD38原代CLL细胞中RasGRP2呈极化分布。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CD38 is a transmembrane exoenzyme that is associated with poor prognosis in chronic lymphocytic leukemia (CLL). High CD38 levels in CLL cells are linked to increased cell migration, but the molecular basis is unknown. CD38 produces nicotinic acid adenine dinucleotide phosphate and adenosine 5'-diphosphate-ribose, both of which can act to increase intracellular Ca2+ levels. Here we show that CD38 expression increases basal intracellular Ca2+ levels and stimulates CLL cell migration both with and without chemokine stimulation. We find that CD38 acts via intracellular Ca2+ to increase the activity of the Ras family GTPase Rap1, which is in turn regulated by the Ca2+-sensitive Rap1 guanine-nucleotide exchange factor RasGRP2. Both Rap1 and RasGRP2 are required for CLL cell migration, and RasGRP2 is polarized in primary CLL cells with high CD38 levels. These results indicate that CD38 promotes RasGRP2/Rap1-mediated CLL cell adhesion and migration by increasing intracellular Ca2+ levels.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Mele S, Devereux S, Pepper AG, et al. Calcium-RasGRP2-Rap1 signaling mediates CD38-induced migration of chronic lymphocytic leukemia cells. Blood Adv. 2018. PMID: 29970392. doi:10.1182/bloodadvances.2017014506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。